Feeling encouraged to cut back on social media use may not translate into lasting behavior changes, especially when the warnings are easily dismissible.
Sanofi courts older pickleball players with COVID-19 vaccine campaign. But the company must overcome COVID-19 fatigue and waning interest in vaccination.
New social media and AI safeguards could set a national baseline for product design and data use.
Agents can connect strategy and execution as marketers target smaller patient and healthcare provider populations.
Apple's large health app user base and no added subscription for most new health features could give it an edge over rivals with similar offerings.
This voter perception aligns with the sectors’ consistently poor reputational ratings in other surveys, and puts more weight on transparency and accountability.
Default scheduling and reminders can take follow-up logistics off new mothers’ plates to close care delivery gaps.
Consistent, candid product information from healthcare and pharma brands can help physicians address health misinformation that leads patients to refuse care and treatment.
A pivotal trial miss could invite tougher questions about valuations and sales forecasts.
The drugs are changing how entire families eat, expanding their impact well beyond individual users.
Oura's health platform ambitions as outlined in its IPO filing could widen revenues, provided medical and wellness partners trust its data and guidance.
Mail-order pharmacies outperform stores digitally. Better online tools can ease medication access and strengthen retention.
In today’s podcast episode, we discuss the main takeaways from Meta’s landmark trial over kids and social media addiction, the safety features it plans to roll out, whether this makes a teen social media ban more or less likely, what we know about social media’s role in youth mental health, and what could change as a result of the settlement. Join Senior Director of Podcasts and host Marcus Johnson, along with Senior Analyst Beth Snyder Bulik and Analyst Marisa Jones. Listen wherever you get your podcasts, or watch on YouTube or Spotify.
Trusted healthcare providers give marketers a credible route to reach anxious patients and encourage action.
That presents an opportunity for retailers with sharp size planning.
Pharma brands and marketers can reduce prescription abandonment by clarifying benefits, expectations, and savings options.
This FAQ covers who influences the wellness shopper, where they buy, and how brands should market responsibly in 2026.
The agency is expediting reviews to help manufacturers boost estradiol patch supplies and limit treatment interruptions as HRT demand rises.
Ads drove 95% more engagement than primetime, helping new drugs break through and older brands stay effective.
Pharma marketers need relevant, digital-friendly messaging that respects HCPs’ heavy workloads.